Total Debt
$49.8M
Net Debt
-$205.1M
Entrada Therapeutics, Inc. currently has $49.8M in total debt. Net debt is -$205.1M after cash offsets. This 'Net Cash' position indicates exceptional financial strength.
Financial Fundamentals
TRDA • Quarterly Data • 5Y View
| Date | Total Debt ($B) | Cash & Inv. ($B) | Net Debt ($B) | Total Assets | Debt/Assets |
|---|---|---|---|---|---|
| 2026-03-31 | 0.05 | 0.25 | -0.21Net Cash | 0.34 | 14.8% |
| 2025-12-31 | 0.05 | 0.30 | -0.24Net Cash | 0.38 | 13.5% |
| 2025-09-30 | 0.05 | 0.33 | -0.27Net Cash | 0.41 | 12.7% |
| 2025-06-30 | 0.05 | 0.35 | -0.30Net Cash | 0.45 | 12.2% |
| 2025-03-31 | 0.06 | 0.38 | -0.33Net Cash | 0.49 | 11.7% |
| 2024-12-31 | 0.06 | 0.42 | -0.36Net Cash | 0.53 | 11.2% |
| 2024-09-30 | 0.06 | 0.45 | -0.39Net Cash | 0.55 | 11.1% |
| 2024-06-30 | 0.06 | 0.47 | -0.41Net Cash | 0.58 | 11.1% |
| 2024-03-31 | 0.07 | 0.33 | -0.26Net Cash | 0.51 | 13.0% |
| 2023-12-31 | 0.07 | 0.35 | -0.28Net Cash | 0.47 | 14.5% |
| 2023-09-30 | 0.07 | 0.35 | -0.28Net Cash | 0.49 | 14.2% |
| 2023-06-30 | 0.07 | 0.38 | -0.30Net Cash | 0.49 | 14.8% |
| 2023-03-31 | 0.02 | 0.41 | -0.40Net Cash | 0.48 | 3.4% |
| 2022-12-31 | 0.03 | 0.19 | -0.16Net Cash | 0.25 | 10.3% |
| 2022-09-30 | 0.03 | 0.22 | -0.19Net Cash | 0.27 | 10.2% |
| 2022-06-30 | 0.03 | 0.24 | -0.21Net Cash | 0.30 | 10.1% |
| 2022-03-31 | 0.03 | 0.26 | -0.23Net Cash | 0.32 | 10.1% |
| 2021-12-31 | 0.00 | 0.29 | -0.29Net Cash | 0.31 | 0.0% |
| 2021-09-30 | 0.00 | 0.12 | -0.12Net Cash | 0.13 | 0.0% |
| 2021-06-30 | 0.00 | 0.14 | -0.14Net Cash | 0.14 | 0.0% |
| 2021-03-31 | 0.00 | 0.04 | -0.04Net Cash | 0.00 | — |
| 2020-12-31 | 0.00 | 0.04 | -0.04Net Cash | 0.04 | 0.0% |
| 2020-03-31 | 0.00 | 0.02 | -0.02Net Cash | 0.00 | — |